Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CYTK |
---|---|---|
09:32 ET | 7847 | 57.17 |
09:34 ET | 7657 | 57.39 |
09:36 ET | 1896 | 57 |
09:38 ET | 1486 | 57.61 |
09:39 ET | 954 | 57.73 |
09:41 ET | 6347 | 57.57 |
09:43 ET | 1576 | 57.79 |
09:45 ET | 1086 | 58.025 |
09:48 ET | 2440 | 58.18 |
09:50 ET | 15134 | 57.71 |
09:52 ET | 13907 | 57.92 |
09:54 ET | 5790 | 57.765 |
09:56 ET | 2745 | 57.635 |
09:57 ET | 1909 | 57.78 |
09:59 ET | 18638 | 57.505 |
10:01 ET | 1892 | 57.65 |
10:03 ET | 1430 | 57.425 |
10:06 ET | 3300 | 57.19 |
10:08 ET | 2251 | 57.12 |
10:10 ET | 1887 | 57.055 |
10:12 ET | 2420 | 57.16 |
10:14 ET | 2240 | 56.99 |
10:15 ET | 1490 | 56.935 |
10:17 ET | 1763 | 56.755 |
10:19 ET | 854 | 56.775 |
10:21 ET | 1100 | 56.88 |
10:24 ET | 1000 | 56.84 |
10:26 ET | 1149 | 56.99 |
10:28 ET | 3026 | 56.865 |
10:30 ET | 1700 | 56.8925 |
10:32 ET | 9387 | 56.825 |
10:33 ET | 3606 | 56.777 |
10:35 ET | 4461 | 56.67 |
10:37 ET | 2886 | 56.83 |
10:39 ET | 1800 | 56.84 |
10:42 ET | 3380 | 56.715 |
10:44 ET | 2596 | 56.62 |
10:46 ET | 1900 | 56.55 |
10:48 ET | 1310 | 56.67 |
10:50 ET | 1478 | 56.65 |
10:51 ET | 1440 | 56.56 |
10:53 ET | 3623 | 56.31 |
10:55 ET | 1240 | 56.41 |
10:57 ET | 1200 | 56.275 |
11:00 ET | 1226 | 56.32 |
11:02 ET | 5080 | 56.47 |
11:04 ET | 1232 | 56.67 |
11:06 ET | 600 | 56.68 |
11:08 ET | 840 | 56.75 |
11:09 ET | 936 | 56.7 |
11:11 ET | 800 | 56.845 |
11:13 ET | 1720 | 56.94 |
11:15 ET | 1880 | 56.98 |
11:18 ET | 960 | 56.88 |
11:20 ET | 2146 | 56.8825 |
11:22 ET | 1511 | 56.86 |
11:24 ET | 1420 | 56.795 |
11:26 ET | 2035 | 56.87 |
11:27 ET | 2453 | 56.84 |
11:29 ET | 1826 | 56.835 |
11:31 ET | 3803 | 56.76 |
11:33 ET | 330 | 56.72 |
11:36 ET | 2690 | 56.715 |
11:38 ET | 400 | 56.72 |
11:40 ET | 2722 | 56.77 |
11:42 ET | 100 | 56.765 |
11:44 ET | 2923 | 56.705 |
11:45 ET | 800 | 56.6475 |
11:47 ET | 6335 | 56.69 |
11:49 ET | 6180 | 56.63 |
11:51 ET | 1600 | 56.635 |
11:54 ET | 3924 | 56.59 |
11:56 ET | 500 | 56.59 |
11:58 ET | 1800 | 56.45 |
12:00 ET | 5942 | 56.4 |
12:02 ET | 300 | 56.38 |
12:03 ET | 1300 | 56.345 |
12:05 ET | 600 | 56.41 |
12:07 ET | 1330 | 56.39 |
12:09 ET | 100 | 56.35 |
12:12 ET | 300 | 56.38 |
12:16 ET | 400 | 56.29 |
12:18 ET | 200 | 56.31 |
12:21 ET | 3032 | 56.37 |
12:23 ET | 700 | 56.3675 |
12:25 ET | 1290 | 56.37 |
12:27 ET | 2100 | 56.405 |
12:30 ET | 1100 | 56.42 |
12:32 ET | 316 | 56.4 |
12:36 ET | 640 | 56.41 |
12:38 ET | 800 | 56.475 |
12:39 ET | 900 | 56.6 |
12:41 ET | 600 | 56.56 |
12:43 ET | 1052 | 56.49 |
12:45 ET | 200 | 56.51 |
12:50 ET | 801 | 56.61 |
12:52 ET | 1310 | 56.56 |
12:54 ET | 667 | 56.48 |
12:56 ET | 1190 | 56.52 |
12:57 ET | 100 | 56.55 |
12:59 ET | 1900 | 56.55 |
01:01 ET | 100 | 56.47 |
01:03 ET | 1100 | 56.515 |
01:06 ET | 100 | 56.48 |
01:08 ET | 221 | 56.507 |
01:10 ET | 449 | 56.495 |
01:12 ET | 427 | 56.54 |
01:14 ET | 8400 | 56.49 |
01:15 ET | 100 | 56.46 |
01:17 ET | 1400 | 56.58 |
01:19 ET | 315 | 56.53 |
01:21 ET | 200 | 56.61 |
01:24 ET | 954 | 56.59 |
01:26 ET | 14800 | 56.59 |
01:28 ET | 7370 | 56.595 |
01:30 ET | 415 | 56.605 |
01:32 ET | 800 | 56.59 |
01:33 ET | 1410 | 56.69 |
01:35 ET | 1750 | 56.69 |
01:37 ET | 300 | 56.755 |
01:39 ET | 107 | 56.7 |
01:42 ET | 600 | 56.7229 |
01:44 ET | 864 | 56.68 |
01:46 ET | 1036 | 56.76 |
01:48 ET | 1039 | 56.857 |
01:50 ET | 300 | 56.93 |
01:51 ET | 400 | 57.03 |
01:53 ET | 300 | 57.165 |
01:55 ET | 1000 | 57.025 |
01:57 ET | 400 | 57.081 |
02:00 ET | 300 | 57.01 |
02:02 ET | 1500 | 57.015 |
02:06 ET | 300 | 57.045 |
02:08 ET | 700 | 57.01 |
02:09 ET | 800 | 56.95 |
02:11 ET | 1140 | 56.92 |
02:13 ET | 200 | 56.95 |
02:15 ET | 500 | 56.81 |
02:18 ET | 1400 | 56.87 |
02:22 ET | 100 | 56.82 |
02:24 ET | 400 | 56.88 |
02:26 ET | 1156 | 56.93 |
02:27 ET | 1407 | 56.95 |
02:29 ET | 1400 | 56.93 |
02:31 ET | 900 | 56.995 |
02:33 ET | 300 | 56.99 |
02:36 ET | 2075 | 56.93 |
02:38 ET | 363 | 56.77 |
02:40 ET | 400 | 56.76 |
02:42 ET | 1000 | 56.7 |
02:44 ET | 900 | 56.725 |
02:45 ET | 1227 | 56.67 |
02:47 ET | 300 | 56.63 |
02:49 ET | 200 | 56.705 |
02:54 ET | 100 | 56.77 |
02:56 ET | 400 | 56.725 |
02:58 ET | 400 | 56.72 |
03:00 ET | 100 | 56.78 |
03:02 ET | 856 | 56.67 |
03:03 ET | 1200 | 56.63 |
03:05 ET | 300 | 56.61 |
03:09 ET | 100 | 56.6 |
03:12 ET | 1101 | 56.73 |
03:14 ET | 200 | 56.69 |
03:16 ET | 3110 | 56.58 |
03:18 ET | 1120 | 56.6 |
03:20 ET | 1490 | 56.62 |
03:23 ET | 1309 | 56.52 |
03:25 ET | 800 | 56.55 |
03:27 ET | 1325 | 56.68 |
03:30 ET | 2000 | 56.635 |
03:32 ET | 1900 | 56.595 |
03:34 ET | 620 | 56.65 |
03:36 ET | 900 | 56.67 |
03:38 ET | 2000 | 56.655 |
03:39 ET | 3910 | 56.59 |
03:41 ET | 1700 | 56.52 |
03:43 ET | 4586 | 56.59 |
03:45 ET | 1225 | 56.6 |
03:48 ET | 3671 | 56.481 |
03:50 ET | 3279 | 56.64 |
03:52 ET | 3638 | 56.58 |
03:54 ET | 4299 | 56.6 |
03:56 ET | 13377 | 56.53 |
03:57 ET | 12798 | 56.53 |
03:59 ET | 142893 | 56.58 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Cytokinetics Inc | 6.7B | -10.5x | --- |
Revolution Medicines Inc | 7.2B | -12.4x | --- |
Viking Therapeutics Inc | 7.3B | -69.1x | --- |
Madrigal Pharmaceuticals Inc | 5.6B | -10.0x | --- |
Krystal Biotech Inc | 5.7B | 55.2x | --- |
Avidity Biosciences Inc | 5.2B | -15.2x | --- |
Cytokinetics, Incorporated is a late-stage, specialty cardiovascular biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which cardiac muscle performance is compromised. The Company specializes in muscle biology and the mechanics of muscle performance. It is developing small molecule drug candidates specifically engineered to impact myocardial muscle function and contractility. Its cardiac muscle contractility program is focused on the cardiac sarcomere. Its clinical-stage drug candidates are: aficamten, which is a next-in-class cardiac myosin inhibitor; omecamtiv mecarbil, which is a cardiac myosin activator; CK-586, which is an additional cardiac myosin inhibitor, and CK-136, which is a cardiac troponin activator. CK-586 is designed to reduce the hypercontractility associated with heart failure with preserved ejection fraction.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $6.7B |
---|---|
Revenue (TTM) | $3.1M |
Shares Outstanding | 117.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.78 |
EPS | $-5.37 |
Book Value | $-3.80 |
P/E Ratio | -10.5x |
Price/Sales (TTM) | 2,134.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -16,148.37% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.